“Real-Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience” (2024) Dermatology Practical & Conceptual, 14(3), p. e2024179. doi:10.5826/dpc.1403a179.